• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小干扰RNA介导的转录基因沉默的治疗潜力

Therapeutic potential of siRNA-mediated transcriptional gene silencing.

作者信息

Morris Kevin V

机构信息

Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Biotechniques. 2006 Apr;Suppl:7-13. doi: 10.2144/000112166.

DOI:10.2144/000112166
PMID:16629382
Abstract

RNA interference (RNAi) and specifically the use of small interfering RNAs (siRNAs) represents a potentially new paradigm in gene knockout technology. Clearly siRNAs can be used to knockdown the expression of a targeted transcript in what has been termed posttranscriptional gene silencing (PTGS). While there are a plethora of reports applying siRNA-mediated PTGS the limitation of the duration of the effect remains. Recently, in human cells, siRNAs have been shown, similar to plants and Schizosaccharomyces pombe, to mediate transcriptional gene silencing (TGS). The observation that siRNAs can function in a TGS manner in human cells suggests that, similar to plants, human genes may also be able to be silenced more permanently via epigenetic modifications. The ramifications of siRNA-mediated TGS in humans suggest that longer term suppression of gene function can be obtained via siRNA-directed chromatin modifications. Undoubtedly the potential to employ siRNA technology is broader than once envisioned in human cells and suggests that siRNA-mediated TGS is not simply limited to PTGS. The potential to utilize siRNAs to direct epigenetic changes in local chromatin structure offers a new therapeutic avenue that could prove remarkably robust and of immeasurable therapeutic value in the directed control of target gene expression.

摘要

RNA干扰(RNAi),特别是小干扰RNA(siRNA)的应用,代表了基因敲除技术中一种潜在的新范例。显然,siRNA可用于在所谓的转录后基因沉默(PTGS)中降低靶向转录本的表达。虽然有大量关于应用siRNA介导的PTGS的报道,但这种效应的持续时间有限。最近,在人类细胞中,siRNA已被证明与植物和粟酒裂殖酵母类似,能够介导转录基因沉默(TGS)。siRNA在人类细胞中以TGS方式发挥作用这一观察结果表明,与植物类似,人类基因或许也能够通过表观遗传修饰被更持久地沉默。siRNA介导的TGS在人类中的影响表明,通过siRNA指导的染色质修饰可以实现基因功能的长期抑制。毫无疑问,在人类细胞中应用siRNA技术的潜力比以往设想的更为广泛,这表明siRNA介导的TGS并不局限于PTGS。利用siRNA指导局部染色质结构的表观遗传变化的潜力提供了一条新的治疗途径,这在定向控制靶基因表达方面可能被证明非常强大且具有不可估量的治疗价值。

相似文献

1
Therapeutic potential of siRNA-mediated transcriptional gene silencing.小干扰RNA介导的转录基因沉默的治疗潜力
Biotechniques. 2006 Apr;Suppl:7-13. doi: 10.2144/000112166.
2
RNA-mediated transcriptional gene silencing in human cells.人类细胞中RNA介导的转录基因沉默
Curr Top Microbiol Immunol. 2008;320:211-24. doi: 10.1007/978-3-540-75157-1_10.
3
The diversity of RNAi and its applications.RNA干扰的多样性及其应用。
Biotechniques. 2006 Apr;Suppl:4-5. doi: 10.2144/000112168.
4
RNA interference: a potential therapeutic tool for silencing splice isoforms linked to human diseases.RNA干扰:一种沉默与人类疾病相关剪接异构体的潜在治疗工具。
Biotechniques. 2006 Apr;Suppl:15-22. doi: 10.2144/000112165.
5
Therapeutic potential of RNAi in metabolic diseases.RNA干扰在代谢性疾病中的治疗潜力。
Biotechniques. 2006 Apr;Suppl:31-6. doi: 10.2144/000112163.
6
Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing.小干扰RNA(siRNA)作为基因沉默近期治疗靶点的潜力。
Curr Drug Targets. 2007 Mar;8(3):469-82. doi: 10.2174/138945007780058988.
7
RNAi as a treatment for HIV-1 infection.RNA干扰作为治疗HIV-1感染的方法。
Biotechniques. 2006 Apr;Suppl:25-9. doi: 10.2144/000112167.
8
Mammalian RNAi: a practical guide.哺乳动物RNA干扰:实用指南。
Biotechniques. 2005 Aug;39(2):215-24. doi: 10.2144/05392RV01.
9
Stable suppression of gene expression by short interfering RNAs targeted to promoter in a mouse embryonal carcinoma stem cell line.通过靶向小鼠胚胎癌细胞系启动子的短发夹 RNA 稳定抑制基因表达。
In Vitro Cell Dev Biol Anim. 2010 Dec;46(10):834-40. doi: 10.1007/s11626-010-9347-6. Epub 2010 Sep 25.
10
RNA-based drugs: from RNA interference to short interfering RNAs.基于RNA的药物:从RNA干扰到小干扰RNA
Curr Pharm Biotechnol. 2004 Aug;5(4):361-8. doi: 10.2174/1389201043376797.

引用本文的文献

1
Argonaute proteins regulate HIV-1 multiply spliced RNA and viral production in a Dicer independent manner.AGO蛋白以一种不依赖于Dicer的方式调控HIV-1多重剪接RNA及病毒产生。
Nucleic Acids Res. 2017 Apr 20;45(7):4158-4173. doi: 10.1093/nar/gkw1289.
2
Transcriptional Gene Silencing (TGS) via the RNAi Machinery in HIV-1 Infections.通过 RNA 干扰机制在 HIV-1 感染中进行转录基因沉默 (TGS)。
Biology (Basel). 2012 Aug 24;1(2):339-69. doi: 10.3390/biology1020339.
3
Promoter-associated RNAs and promoter-targeted RNAs.启动子关联 RNA 和启动子靶向 RNA。
Cell Mol Life Sci. 2012 Sep;69(17):2833-42. doi: 10.1007/s00018-012-0953-1. Epub 2012 Mar 14.
4
Mobilization-competent Lentiviral Vector-mediated Sustained Transcriptional Modulation of HIV-1 Expression.具备动员能力的慢病毒载体介导的HIV-1表达的持续转录调控
Mol Ther. 2009 Feb;17(2):360-8. doi: 10.1038/mt.2008.268. Epub 2008 Dec 9.
5
Maintaining the silence: reflections on long-term RNAi.保持沉默:关于长期RNA干扰的思考
Drug Discov Today. 2008 Nov;13(21-22):917-31. doi: 10.1016/j.drudis.2008.06.008. Epub 2008 Aug 7.
6
Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain.炎性肌肉疼痛后三叉神经节神经元中选择性微小RNA的下调
Mol Pain. 2007 Jun 8;3:15. doi: 10.1186/1744-8069-3-15.